Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06292715

Microwave Ablation With Splenic Artery Occlusion for Secondary Hypersplenism

A Single-Arm Clinical Study Evaluating Microwave Ablation of the Spleen Combined With Splenic Artery Occlusion for Secondary Hypersplenism Treatment

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
35 (estimated)
Sponsor
Tianjin Medical University Cancer Institute and Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study assesses the effectiveness of microwave ablation of the spleen in conjunction with splenic artery occlusion for treating secondary hypersplenism.

Detailed description

This open-label, single-arm, single-center clinical trial investigates the combined approach of microwave ablation of the spleen and splenic artery occlusion for managing secondary hypersplenism.

Conditions

Interventions

TypeNameDescription
PROCEDUREmicrowave ablation of the spleenUltrasound-guided percutaneous puncture for splenic ablation treatment
OTHERSplenic artery balloon implantationSplenic artery balloon implantation

Timeline

Start date
2024-01-20
Primary completion
2025-12-31
Completion
2026-12-31
First posted
2024-03-05
Last updated
2024-03-05

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06292715. Inclusion in this directory is not an endorsement.

Microwave Ablation With Splenic Artery Occlusion for Secondary Hypersplenism (NCT06292715) · Clinical Trials Directory